logo
Book a meeting
Sudo Biosciences

Sudo Biosciences

Biotechnology, 2701 Kent Ave, Menlo Park, California, 47906, United States, 11-50 Employees

sudobio.com

  • LinkedIn

phone no Phone Number: +15*********

Who is SUDO BIOSCIENCES

Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients lives. Our lead programs target the tyrosine kin...

Read More

lock icon Get Full Access
map
  • 2701 Kent Ave, Menlo Park, California, 47906, United States Headquarters: 2701 Kent Ave, Menlo Park, California, 47906, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7379 | NAICS Code: 541519 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SUDO BIOSCIENCES

Sudo Biosciences Org Chart and Mapping

Employees
Fenella Smith

Fenella Smith

Executive Assistant/Office Manager

See Full Org Chart arrow
email-formate-icon
View Email Formats for Sudo Biosciences
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Sudo Biosciences

Answer: Sudo Biosciences's headquarters are located at 2701 Kent Ave, Menlo Park, California, 47906, United States

Answer: Sudo Biosciences's phone number is +15*********

Answer: Sudo Biosciences's official website is https://sudobio.com

Answer: Sudo Biosciences's revenue is $100 Million to $250 Million

Answer: Sudo Biosciences's SIC: 7379

Answer: Sudo Biosciences's NAICS: 541519

Answer: Sudo Biosciences has 11-50 employees

Answer: Sudo Biosciences is in Biotechnology

Answer: Sudo Biosciences contact info: Phone number: +15********* Website: https://sudobio.com

Answer: Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients lives. Our lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access